Fate Therapeutics logo
Fate Therapeutics FATE
$ 2.08 -6.53%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Fate Therapeutics EV/EBITDA Ratio 2011-2024 | FATE

Annual EV/EBITDA Ratio Fate Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-25.4 -62 -16.9 -9.92 -7.75 -0.333 -0.303 -3.07 0.9 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.9 -62 -13.9